Market Cap
₹21,178 Cr.
P/E
35.51
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics
Other Income
Other Income is not affecting ratios of the company
Depreciation Effect
Company is depreciating a lower percentage of assets. This is contributing to an increase in Net Profit
Pledge
Promoters have not pledged a significant portion of their holding
Revenue Recognition
Unable to calculate due to limited data
Capex vs ROCE
ROCE of the company has increased over the last three years
Contingent Liabilities
Company does not have significant contingent liabilities
Retail Holding
Retail has been selling the stock which is usually a good time to buy
Share price
Share price has increased over last 10 years due to earnings
ROE
Net Profit Margin is responsible for ROE increase over last 10 years
Working Capital
Working Capital of the company seems to be under control
Debt
Company should not have issues servicing its debt
Promoter Holding
Promoter has not sold any shares in the last 90 days
Current vs Historic Valuation
Company is trading at a premium to 3 year historic valuations
ROE
Latest
48.64%
3yr Average
37.87%
5yr Average
29.55%
Net Profit Margin
Latest
22.4%
3yr Average
23.6%
5yr Average
19.61%
ROCE
Latest
35.2%
3yr Average
26.66%
5yr Average
23.11%
Debt to Equity
Latest
-
3yr Average
0.0
5yr Average
0.0
Market Share
6.24% (as of Jul 22)
Anti - Diabetes - Market Share
0.32% (as of Jul 22)
Anti-Infectives - Market Share
0.05% (as of Mar 19)
Antineo Plastic - Market Share
1.97% (as of Jul 22)
Cardiovascular - Market Share
0.55% (as of Mar 19)
Dermatology - Market Share
1.80% (as of Jul 22)
Gastro-Intestinal - Market Share
2.67% (as of Mar 19)
Neurological - Market Share
2.87% (as of Mar 19)
Pain - Market Share
1.60% (as of Dec 22)
Pharmaceutical Sector - Market Share
3.38% (as of Mar 19)
Respiratory - Market Share
0.10% (as of Mar 19)
Sex Stimulants - Market Share
20.16% (as of Jul 22)
Vaccines - Market Share
0.12% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Brands
    Allegra
    Avil
    Combiflam
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis